0 Comments
0 Shares
2K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...0 Comments 0 Shares 1K Views 0 Reviews
-
Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...0 Comments 0 Shares 1K Views 0 Reviews
-
What Is Driving Demand in the Azacitidine Market for Cancer Treatment?Executive Summary Azacitidine Market Size and Share Across Top Segments CAGR Value The global azacitidine market was valued at USD 90.24 billion in 2024 and is expected to reach USD 165.79 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.90%, primarily driven by increasing geriatric population By utilizing few steps or a number of...0 Comments 0 Shares 1K Views 0 Reviews